• Guided and supervised a junior MSL in the execution of the field strategy, ensuring consistent delivery of key messages and effective capture of insights.• Established strategic relationships with opinion leaders in dermatology and rheumatology, significantly expanding my network of healthcare professionals.• Disseminated scientific and clinical data, supporting the efficacy and safety of Tremfya® (guselkumab) and Stelara® (ustekinumab) in the treatment of psoriasis and psoriatic arthritis.• I collected and presented relevant information to enhance medical strategy, contributing to informed decision making.

• Participated in the creation and execution of a training program for the sales team, achieving the certification of 100% of the trained members.• Led the planning and successful execution of a virtual preceptorship for retinologists and ophthalmologists, facilitating the transfer of specialized knowledge.• Cultivated strong relationships with opinion leaders in the field of ophthalmology, strengthening the network of influential professionals.• Disseminated scientific and clinical information to support the efficacy and safety of Lucentis® (ranibizumab) and brolucizumab in retinal diseases.• Successfully implemented the medical field strategy for the launch of brolucizumab, contributing to its adoption in the medical community.• Collected relevant information to enrich medical and commercial strategies, optimizing decision making.• Contributed to the review and improvement of medical and promotional material, ensuring accuracy and consistency of information.• Made scientific presentations to diverse audiences, effectively transmitting knowledge about advances in ophthalmology.

• Led the planning and execution of the "First update meeting on Human Papilloma Virus and cervical cancer", extending the business relationship for two additional years.• Developed a user's guide to address common problems, decreasing operational-related phone calls by 25%.• Provided technical and scientific support to clinics enrolled in ISSSTE's "Cervical Cancer Screening Program", optimizing the efficiency of the process.• Trained new users in the handling of Panther equipment for the molecular detection of human papillomavirus, ensuring a smooth and accurate adoption.• Ensured the supply of reagents and the proper functioning of ISSSTE laboratories involved in human papillomavirus detection.• Forged strong relationships with regional and national leaders of cervical cancer screening programs, strengthening collaboration and presence.

• Designed and performed biotechnological experiments. • Prepared reagents for experimentation: Buffers, bacterial medium culture, competent cells. • Executed PCR, electrophoresis, molecular cloning, bacterial culture, plasmid DNA purification.• Developed a novel strain with increased mercury resistance.